New Technology Detects Cervical Lesions

Published Online: Tuesday, February 1, 2005

A review of 3 earlier studies found that using speculoscopy—bright light technology—immediately following a Pap smear may help physicians discover more cervical cancer lesions than the Pap test alone. A negative, however, is that the combination approach may also up the risk of false positives. Analyses of the studies found that using speculoscopy together with Pap smear detected an additional 42 to 62 lesions per 1000 patients screened. The evidence also showed an increase in the number of false positives from 55 to 111 per 1000 patients screened. The reviewers noted, that, because the review found only 3 studies that compared Pap smear alone with Pap smear and speculoscopy, the current data regarding the technology is not strong.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues